Image Rotator

The National Cancer Institute (NCI) has named Sanford Health an NCI Community Oncology Research Program (NCORP) community site and awarded it a five-year grant totaling more than $7.1 million to recruit participants for cancer clinical trials, quality of life studies and cancer-care delivery research.
Sanford Receives NIH Grant for Cancer Research
The National Cancer Institute (NCI) has named Sanford Health an NCI Community Oncology Research Program (NCORP) community site and awarded it a five-year grant totaling more than $7.1 million to recruit participants for cancer clinical trials, quality of life studies and cancer-care delivery research.

Homepage

 

Children's Health Research

The Sanford Children’s Health Research Center is leading the way in translational pediatric research, including cancer and rare diseases.

Learn More

 

The Sanford Project

The Sanford Project is focused on restoring a patients’ own pancreatic insulin production by reviving their insulin-producing pancreatic islet beta cells.

Learn More

 

Clinical Research at Sanford Health

Sanford Health offers a robust clinical research platform where bench and translational research can be combined seamlessly with medical care delivery.

Learn More

Homepage

  • Kruer Recognized by Doris Duke Foundation

    Physician-scientist receives grant totaling more than $500,000 to research pediatric movement disorders.

    Learn More

  • Sanford Project Publishes Results

    The outcome of the Sanford Project’s two-year clinical study, REPAIR-T1D, appears in a national journal.

    Learn More

  • Breast Cancer Study Published in JAMA

    Three-dimensional mammography finds significantly more invasive cancers, according to a study from Edith Sanford.

    Learn More

  • Dr. Kelly Appears in National Journals

    Sanford surgeon, Dr. Pat Kelly, was recently published in a pair of national journals for two unique methods to treat aneurysms.

    Learn More

  • Dr. Savinov Published in Diabetes

    A team from The Sanford Project has identified a potential biomarker and therapeutic target for type 1 diabetes.

    Learn More

Twitter Updates on Sanford Research
  • @DrDavidPearce
    Drug slows down advanced HER2 #breastcancer http://t.co/pxsEiEObql in phase III trial #EdithSanford

  • @DrDavidPearce
    RT @stemschools: Educating Educators is an Important Part of STEM Success http://t.co/WY1VP44uyQ

  • @DrDavidPearce
    RT @KimberlyatEdith: Fast Company reports on cows @SanfordHealth #SanfordResearch @EdithSanford:http://t.co/zpOx6jvlD3

  • @kkempken
    @SanfordCoRDS #CoRDSchat I'm looking forward to attending my first Twitter chat this morning with CoRD!

  • @vitiellp
    @DrDavidPearce

  • @DrDavidPearce
    #Metabolomics and #Homeostasis key elements to understanding #rarediseases described here http://t.co/5RME0tBX3G

  • @DrDavidPearce
    International Rare Disease Research Consortium #IRDiRC executive committee meeting http://t.co/NPQWPp9gLP bringing collaborations together

  • @SanfordCoRDS
    RT @Stephanies_Hope: Thanks for following Stephanie's Hope @SanfordCoRDS and @TabbyMitchell ! I have 8 followers now, woohoo!! ;) #RARE2013…